RNS Number : 5185X
Zinnwald Lithium PLC
21 December 2023
 

 

Zinnwald Lithium plc / EPIC: ZNWD.L / Market: AIM / Sector: Mining

 

21 December 2023

 

Zinnwald Lithium plc ("Zinnwald Lithium" or the "Company")

 

Mineral Resource Estimate Update

 

Zinnwald Lithium plc, the European focused lithium company, provides an update regarding the publication of a revised Mineral Resource Estimate ("MRE") at its integrated Zinnwald Lithium Project (the "Project") in Germany.  Whilst the revised MRE is well advanced, further work is required before it can be finalised, and it is now expected to be published in Q1 2024.  As previously stated, the Company anticipates that the inclusion of Albite Granite mineralisation within the MRE will significantly increase the Zinnwald Lithium Project's Mineral Resource base, which should strengthen the Company's potential operational and production capacity.

 

*ENDS*

 

 For further information visiwww.zinnwaldlithium.com or contact:

 

Anton du Plessis

Cherif Rifaat

Zinnwald Lithium plc

info@zinnwaldlithium.com

David Hart

Dan Dearden-Williams

Allenby Capital

(Nominated Adviser)

+44 (0) 20 3328 5656

Michael Seabrook

Adam Pollock

Oberon Capital Ltd

(Joint Broker)

+44 (0) 20 3179 5300

Richard Greenfield

Charles Bendon

Tamesis Partner LLP

(Joint Broker)

+44 (0) 20 3882 2868

Isabel de Salis

Paul Dulieu

St Brides Partners

(Financial PR)

zinnwald@stbridespartners.co.uk

 

 

Notes

AIM quoted Zinnwald Lithium plc (EPIC: ZNWD.L) is focused on becoming an important supplier of lithium hydroxide to Europe's fast-growing battery sector. The Company owns 100% of the Zinnwald Lithium Project in Germany, which has an approved mining licence, is located in the heart of Europe's chemical and automotive industries and has the potential to be one of Europe's more advanced battery grade lithium projects.

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UPDFEMFMSEDSEDE